Tag: AMAG Pharmaceuticals
Emerging Therapeutics in Preeclampsia Management
Preeclampsia is a pregnancy related complication that affects over 5% to 8% of pregnancies or about 3,00,000 women in the US alone. An estimated...
Emerging Paradigms in the Anticoagulant Industry
Anticoagulants have wide applications for prevention of blood clots in treatment of conditions such as pulmonary embolism, deep vein thrombosis (DVT), atrial fibrillation, stroke...